|1.||Menezes, Leociley R A: 1 article (05/2015)|
|2.||Rocha, Suellen L A: 1 article (05/2015)|
|3.||Soares, Milena B P: 1 article (05/2015)|
|4.||Rocha, Clarissa A Gurgel: 1 article (05/2015)|
|5.||Bezerra, Daniel P: 1 article (05/2015)|
|6.||Baliza, Ingrid R S: 1 article (05/2015)|
|7.||Dias, Rosane B: 1 article (05/2015)|
|8.||Costa, Emmanoel V: 1 article (05/2015)|
|9.||Boušová, Iva: 1 article (01/2015)|
|10.||Ambrož, Martin: 1 article (01/2015)|
07/01/2007 - "The results of this study show that nerolidol displays antiulcer activity, as it significantly inhibited the formation of ulcers induced in different animal models. "
07/01/2007 - "In the stress-induced ulcer model, a significant reduction of the ULI in animals treated with nerolidol (50, 250 and 500 mg/kg) and cimetidine (100 mg/kg) was observed, compared to the control group (p < 0.05). "
07/01/2007 - "In the ethanol-induced model percentage of inhibition of ulcer was 34.20, 52.63, 87.63 and 50.87% in groups treated with 50, 250, 500 mg/kg of nerolidol and 30 mg/kg of omeprazol (positive control), respectively. "
07/01/2007 - "The percentage of inhibition of ulcer was 41.22, 51.31, 56.57 and 53.50% in groups treated with 50, 250, 500 mg/kg of nerolidol and 100 mg/kg of cimetidine (positive control), respectively. "
07/01/2007 - "In indomethacin-ulcer the percentage of inhibition of ulcer was 34.69, 40.80, 51.02 and 46.93% in groups treated with 50, 250, 500 mg/kg of nerolidol and 100 mg/ kg of cimetidine (positive control), respectively. "
05/01/2005 - "amazonensis-infected macrophages with 100 microM nerolidol resulted in 95% reduction in infection rates. "
08/01/2014 - "Nerolidol dramatically improved the skin permeation and deposition of terbinafine in the skin that might help to optimize targeting of the drug to the epidermal sites as required for both of superficial and deep cutaneous fungal infections."
05/01/2015 - "brasiliensis presents trans-nerolidol, germacrene D, trans-caryophyllene, α-humulene, and farnesene as major constituents and is able to inhibit cell proliferation in cultures as well as in tumor growth in mice. "
11/01/1999 - "Bioassay-directed fractionation of the flowers and leaves of Ratibida columnifera using a hormone-dependent human prostate (LNCaP) cancer cell line led to the isolation of 10 cytotoxic substances, composed of five novel xanthanolide derivatives (2-4, 7, and 8), a novel nerolidol derivative (9), and three known sesquiterpene lactones, 9alpha-hydroxy-seco-ratiferolide-5alpha-O-angelate+ ++ (1), 9alpha-hydroxy-seco-ratiferolide-5alpha-O-(2-methylbut yrate) (5), 9-oxo-seco-ratiferolide-5alpha-O-(2-methylbutyrate) (6), as well as a known flavonoid, hispidulin (10). "
05/01/2005 - "Nonetheless, the in vitro activity of nerolidol against these parasites may prove a useful tool for the development of new drugs for the treatment of leishmaniasis. "
01/01/2014 - "The in vitro cytotoxicity of nerolidol was similar to that of miltefosine, and nerolidol has high hydrophobicity; thus, nerolidol might be used in drug delivery systems, such as lipid nanoparticles to treat leishmaniasis."
|7.||Vitamin A (Retinol)
|9.||Phenylethyl Alcohol (Phenethyl Alcohol)